Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carlos Blood Tonic
- Development stage
- Unknown
- Lead developer
- Carlos Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Carlos Blood Tonic is an oral over-the-counter generic blood tonic manufactured and distributed by Carlos Pharmaceuticals in Nigeria. It is formulated to treat and prevent iron-deficiency anemia, support red blood cell production, and improve overall vitality. As a nutritional supplement and hematinic, it typically contains iron in combination with essential B-complex vitamins and folic acid, which are critical cofactors in erythropoiesis and cellular metabolism. The product is approved and commercially available in Nigeria as part of Carlos Pharmaceuticals' portfolio of essential generic medicines.
- Brand names
- Carlos Blood Tonic
Beyond the preview
Go deeper on Carlos Blood Tonic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Carlos Blood Tonic.